内視鏡デバイスの米国市場

Abstract

United States Endoscopy Devices Medical Equipment Industry Report

Summary

This report is an essential source for in-depth information and data relating to United States endoscopy devices medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the endoscopy devices medical equipment in United States.

Scope

・ The report provides sector information broken down into detailed categories and segments in country.
・ Total revenues, products sold, end users, and average pricing.
・ Market shares of all the key competitors.
・ Key pipeline products that are set to shape the market, broken down by sector.
・ Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
・ Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
・ Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
・ Key mergers and acquisitions, partnerships, private equity investments and IPOs.
・ Customer, hospitals and physicians data.

Note: Some content types may not be available in this report

Reasons to buy

・ Gain a strong understanding of the industry at a global level, with break downs for the country
・ Evaluate and compare the attractiveness of the market in the country.
・ Identify growth segments and opportunities in each industry sector within the country.
・ Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
・ Analyze the competitiveness of the market in the country and identify hotspots.
・ Develop strategies based on the latest product, brand, expansion and research and development news in the country.
・ Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
・ Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Table of Contents

Table of Contents

1 Table Of Contents
1 Table Of Contents 2
1.1 List Of Tables 8
1.2 List Of Figures 10
2 Introduction 11
2.1 What Is This Report About? 11
2.2 Definitions 11
2.2.1 Endoscopy Devices 11
3 Healthcare Sector Review 13
3.1 Healthcare Expenditure 13
3.2 Healthcare Infrastructure 18
3.2.1 Healthcare Personnel Data 20
3.2.2 Healthcare Facilities Data 23
4 Endoscopy Devices in United States 25
4.1 Endoscopy Devices Overall Revenues (2000-2012) 25
4.2 Endoscopy Devices Overall Volume (2000-2012) 31
4.3 Endoscopy Devices Overall Company Shares (2005-2006) 34
4.4 Flexible Endoscope in United States 35
4.4.1 Flexible Endoscope Overall Revenues (2000-2012) 35
4.4.2 Flexible Endoscope Overall Volume (2000-2012) 37
4.4.3 Flexible Endoscope Average Price (2000-2012) 39
4.4.4 Flexible Endoscope Distribution Share (2005-2006) 41
4.4.5 Flexible Endoscope Company Share (2005-2006) 42
4.5 Rigid Endoscope in United States 43
4.5.1 Rigid Endoscope Overall Revenues (2000-2012) 43
4.5.2 Rigid Endoscope Overall Volume (2000-2012) 45
4.5.3 Rigid Endoscope Average Price (2000-2012) 47
4.5.4 Rigid Endoscope Distribution Share (2005-2006) 49
4.5.5 Rigid Endoscope Company Share (2005-2006) 50
5 OLYMPUS CORPORATION Company Profile 52
5.1 Company Overview 52
5.2 Business Overview 52
5.2.1 Imaging Systems Business 52
5.2.2 Information and Communication Business 53
5.2.3 Life Sciences Business 53
5.2.4 Medical Systems Business 54
5.2.5 Others 55
5.2.6 Major Products and Services 55
5.2.7 History 56
5.3 Value Chain Analysis 58
5.3.1 Manufacturing 58
5.3.2 Product Development 59
5.3.3 Sales and Marketing 59
5.4 SWOT Analysis 59
5.4.1 OLYMPUS CORPORATION Strengths 60
5.4.2 OLYMPUS CORPORATION Weaknesses 61
5.4.3 OLYMPUS CORPORATION Opportunities 61
5.4.4 OLYMPUS CORPORATION Threats 62
5.5 Financial and Operational Review 63
5.5.1 Financial Statements 63
5.5.2 Share Holding Structure 64
5.6 Locations And Subsidiaries 64
5.7 Financial Deals Landscape 66
5.7.1 Spiration Secures $18.5 Million In Series G Round Of Financing 66
5.7.2 Terumo Forms Joint Venture With Olympus Corporation 68
5.7.3 Olympus Signs An Agreement With Visen Medical 69
5.7.4 Olympus Acquires Stake In Cytori Therapeutics 70
5.7.5 Olympus Corporation Forms A Joint Venture With Movaz Networks 72
5.7.6 Spiration Secures $13.4 Million In Series F Financing 73
5.7.7 Olympus Corporation Forms Partnership With Takano 75
5.7.8 Olympus To Acquire Gyrus Group 76
5.8 Recent Developments 78
5.8.1 Apr 01, 2008: Olympus Appoints New CEO 78
5.8.2 Feb 04, 2008: Olympus Reports Q3 Fiscal 2008 Results 79
5.8.3 Nov 06, 2007: Olympus Reports Q2 Fiscal 2008 Results 79
5.8.4 Jul 30, 2007: Olympus Reports Q1 Fiscal 2008 Results 79
5.8.5 Jul 30, 2007: Olympus Reports H1 Fiscal 2006 Results 79
5.8.6 Jul 30, 2007: Olympus Reports Q1 Fiscal 2006 Results 80
5.8.7 Jul 30, 2007: Olympus Reports Fiscal 2006 Results 80
5.8.8 Jul 30, 2007: Olympus Reports Q3 Fiscal 2006 Results 80
5.8.9 Jul 30, 2007: Olympus Reports Q1 Fiscal 2007 Results 80
5.8.10 May 08, 2007: Olympus Reports Fiscal 2007 Results 80
5.8.11 Feb 05, 2007: Olympus Reports Q3 Fiscal 2007 Results 80
5.9 OLYMPUS CORPORATION Pipeline Products 81
5.9.1 OLYMPUS CAPSULE ENDOSCOPE SYSTEM 81
5.9.2 Single Balloon Enteroscopy (SBE) system 81
6 KARL STORZ GmbH & Co. KG Company Profile 83
6.1 Company Overview 83
6.2 Business Overview 83
6.2.1 Major Products and Services 83
6.2.2 History 84
6.3 Locations And Subsidiaries 84
6.4 Financial Deals Landscape 86
6.4.1 KARL STORZ Signs An Agreement With EndoGastric Solutions 86
7 PENTAX Medical Company Profile 88
7.1 Company Overview 88
7.2 Business Overview 88
7.2.1 Major Products and Services 89
7.2.2 History 90
7.3 Locations And Subsidiaries 90
7.3.1 Other Locations & Subsidiaries 91
7.4 Financial Deals Landscape 92
7.4.1 PENTAX Medical Company Acquires Operating Assets Of KayPENTAX (formerly Kay Elemetrics) 92
7.5 Recent Developments 93
7.5.1 Oct 06, 2007: PENTAX Appoints VP, Sales And Marketing 93
8 B. Braun Melsungen AG Company Profile 95
8.1 Company Overview 95
8.2 Business Overview 95
8.2.1 Aesculap division 95
8.2.2 B. Braun Avitum division 95
8.2.3 Hospital Care division 96
8.2.4 Out Patient Market (OPM) division 96
8.2.5 Major Products and Services 97
8.2.6 History 97
8.3 Value Chain Analysis 99
8.3.1 Manufacturing 99
8.3.2 Product Development 100
8.3.3 Sales and Marketing 101
8.4 SWOT Analysis 101
8.4.1 B. Braun Melsungen AG Strengths 101
8.4.2 B. Braun Melsungen AG Weaknesses 102
8.4.3 B. Braun Melsungen AG Opportunities 103
8.4.4 B. Braun Melsungen AG Threats 103
8.5 Financial and Operational Review 104
8.5.1 Financial Statements 104
8.5.2 Financial Ratios 105
8.6 Locations And Subsidiaries 106
8.7 Financial Deals Landscape 108
8.7.1 B. Braun Signs An Agreement With Nipro 108
8.7.2 B. Braun Enters Into A Licensing Agreement With Chartie Hospital 109
8.7.3 B. Braun Signs An Agreement With Charite 110
8.8 Recent Developments 111
8.8.1 Mar 26, 2008: B. Braun Reports 2007 Results 111
8.8.2 Oct 25, 2007: B. Braun Melsungen Signs Distribution Agreement With NIPRO 113
8.8.3 May 25, 2007: B. Braun Melsungen Enters Into Strategic Alliance With Health Robotics 114
8.8.4 Mar 28, 2007: B. Braun Melsungen Reports 2006 Results 114
8.8.5 Mar 24, 2007: B. Braun Melsungen To Shut Its Plant In Puerto Rico 115
8.8.6 Mar 15, 2007: B. Braun Melsungen To Invest In Medical Technology Production 115
8.8.7 Sep 19, 2005: B. Braun Medical Opens Manufacturing Facility In Suzhou 115
8.9 B. Braun Melsungen AG Pipeline Products 116
8.9.1 Coroflex Please 116
8.9.2 SeQuent Please 118
9 Fujinon Corporation Company Profile 121
9.1 Company Overview 121
9.2 Business Overview 121
9.2.1 Major Products and Services 122
9.2.2 History 122
9.3 Locations And Subsidiaries 124
9.4 Financial Deals Landscape 125
9.4.1 Given Imaging And Fujinon Corporation Sign Global Strategic Collaboration 125
9.5 Recent Developments 126
9.5.1 Jul 11, 2006: Fujinon Reports Fiscal 2007 Results 126
10 Regulation System 127
10.1 Medical Equipment Approval Process 127
10.1.1 Pre-market Approval Process 128
10.1.2 Intended use and Indications for use 128
10.1.3 Predicate Device 128
10.1.4 Safe and Effective 129
10.1.5 Other Category Devices 131
10.1.6 Post-Market Approval Process 132
10.1.7 Compliance and Enforcement 132
10.1.8 Registration Fee 133
10.1.9 Approval Time 133
11 Pricing and Reimbursement 134
11.1 Government Policies 134
11.2 Private Insurance 135
11.3 Diagnosis Related Groups (DRG) 136
12 Distribution Structure 137
12.1 Distribution Structure 137
13 APPENDIX 138
13.1 Methodology 138
13.2 Coverage 139
13.3 Secondary Research 139
13.4 Primary Research 140
13.5 Models 140
13.6 Forecasts 141
13.7 Expert Panels 141
13.8 Currency Conversion 142
13.9 Contact Us 143
13.10 Disclaimer 143